North East England’s life sciences sector is a fast-growing success story. Our region is the UK Manufacturing centre for the Life Sciences sector, with 95% of all pharmaceutical production exported for global use.
Our region has the UK’s highest per capita value of exports of medicinal and pharmaceuticals products to the world.
Sector strength is founded on a base of 165 life sciences-related businesses supported by 85 specialist supply chain companies.
Pharmaceuticals manufacturers like MSD in Cramlington, Northumberland, thrive in our region. It employs 400 people at one of the most advanced plants of its type in the world – a recognised centre of excellence for tablet manufacturing and packaging.
GSK produces over 500,000 units a day at its 60-acre manufacturing site in County Durham, employing 1,100 people.
Our extensive supply chain to the pharmaceuticals industry includes companies in drug discovery, custom synthesis, specialist bio-processing and technical support.
Our region has strong clusters of life sciences firms centred in County Durham, Newcastle, Gateshead and Northumberland, with development space available for investors next to existing companies.
These firms and many more have taken advantage of our superb combination of highly competitive labour costs, low property costs and world best academic R & D in the sector.
The North East boasts a number of exceptional quality, available sites and properties for life sciences companies – including NETPark, the North East Business and Innovation Centre, Newcastle Science Central and Newcastle Bio-Incubator.
The Financial Times Benchmarking Study found a typical 50-person life sciences R & D operation in North East England would save around £1m per annum in costs compared to South East England.
Investors benefit from access to outstanding academic research, centres of excellence and support organisations.
The Centre for Process Innovation (CPI) is a major international technology innovation hub. The Darlington based National Biologics Manufacturing Centre, provides companies with open access facilities and expertise to help them develop, prove and commercialise new and improved processes and technologies.
The National Formulation Centre, opening in 2017 at NETPark, will provide facilities and expertise to facilitate radical product and process design.
Newcastle University is a Pfizer INSPIRE site – a programme aiming to create strategic partnerships in locations where the world’s most impactful and successful research is being conducted. This research includes work at the Campus for Ageing and Vitality, a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. This programme is soon to be relocated to Science Central.
It is widely recognised as the prime centre of excellence in this area anywhere in Europe, leading research into how society combats age-related diseases like Alzheimer’s.
Companies such as Biosignatures and Total Lab are taking advantage of our strength in the digital health sector to lead technological advances in next generation molecular diagnostics tests, using software to research genomics and biochemistry.
North East England also has significant clinical trials platforms across different disease and therapeutic areas, with an excellent record for bringing patients into trials when compared with other UK regions.
For instance, in 2014/15 the Newcastle upon Tyne Hospitals NHS Foundation Trust ranked first in the UK in the number of recruiting clinical studies.